Download Files:
Claficapavir
$130 – $1,200
Products Details
Product Description
– Claficapavir (A1752) is a specific nucleocapsid protein (NC) inhibitor with an IC50 around 1 μM. Claficapavir strongly binds the HIV-1 NC (Kd=20 nM) thereby inhibiting the chaperone properties of NC and leading to good antiviral activity against the HIV-1[1].
Web ID
– HY-145560
Storage Temperature
– -20°C, 3 years; 4°C, 2 years (Powder)
Shipping
– Room Temperature
Applications
– COVID-19-anti-virus
Molecular Formula
– C17H12ClNO4S2
References
– [1]Kim MJ, et al. Identification and characterization of a new type of inhibitor against the human immunodeficiency virus type-1 nucleocapsid protein. Retrovirology. 2015;12:90. Published 2015 Nov 6.
CAS Number
– 2055732-24-4
Molecular Weight
– 393.86
Compound Purity
– 99.14
SMILES
– O=C(N(C(S/1)=S)CCC(O)=O)C1=CC2=CC=C(C3=CC=C(C=C3)Cl)O2
Clinical Information
– No Development Reported
Research Area
– Infection
Solubility
– DMSO : 200 mg/mL (ultrasonic;warming;heat to 40°C)
Target
– HIV
Isoform
– HIV-1
Pathway
– Anti-infection
Product type
– Reference compound
Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.
